SyntheticMR signs agreement to acquire Finnish Combinostics Oy
28 November 2024, 22:55 CET SyntheticMR AB ("SyntheticMR" or the "Company") has signed an agreement to acquire Finnish Combinostics Oy ("Combinostics"), through the acquisition of all shares in Combinostics, a leading medical technology and software solutions company focusing on cloud-based and AI-driven platforms. The acquisition is subject to approval by an Extraordinary General Meeting. Notice of the EGM will be published through a separate press release. The purchase price amounts to a total of EUR 4.3 million (corresponding to approximately SEK 49.6 million[1] ), of which